Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Device Center Seeks Panel’s Advice On Conveying Product Risks

This article was originally published in The Gray Sheet

Executive Summary

FDA says it tries to proactively communicate device risks to physicians and patients, but unique challenges in the industry sometimes hinder its efforts
Advertisement

Related Content

When Communicating Product Risks, FDA Should Involve Firms – AdvaMed
When Communicating Product Risks, FDA Should Involve Firms – AdvaMed
Race For FDA Commissioner Almost Over: Will It End With Sharfstein Or Califf?
Race For FDA Commissioner Almost Over: Will It End With Sharfstein Or Califf?
FDA Teams With WebMD For Wider Dissemination Of Product Safety Info
FDA Teams With WebMD For Wider Dissemination Of Product Safety Info
FDA Announces Sentinel Program; Stakeholders Watch For Details
FDA Announces Sentinel Program; Stakeholders Watch For Details
Advertisement
UsernamePublicRestriction

Register

MT026459

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel